An implantable glucose sensor based on carbon nanotubes could allow patients with diabetes to monitor their blood sugar levels without the need for daily pinprick tests.

The Glucose Sensor Program, which officially launches June 1, will give Islanders access to glucose sensor technology at a reduced cost through local P.E.I. pharmacies.

Engineers have developed a new sensor that could inexpensively test for glucose levels in the exhaled breaths of diabetics or indicators for breast cancer using saliva.

Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM+, on Tuesday. The trial data ...

These color-enhanced scanning electron microscope images show nanosheets resembling tiny rose petals. The nanosheets are key components of a new type of biosensor that can detect minute concentrations ...

Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1MANCHESTER, N ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes.

Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that ...